Skip to content

The effects of etomidate and ketamine on outcome of adult patients with multiple trauma requiring tracheal intubation

Comparison of the effects of etomidate versus ketamine on outcome of adult patients with multiple trauma requiring rapid sequence intubation

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171106037280N3
Enrollment
80
Registered
2019-01-28
Start date
2019-01-10
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intubation in trauma patient.

Interventions

Intervention 1: Intervention group1:ketamine: ketamine 3 mg/kg IV infusion, administered once at the beginning of the intervention for induction during rapid sequence intubation. Intervention 2: Inter

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All adult multiple trauma patients referring to Sanandaj Kowsar Hospital emergency department requiring rapid sequence tracheal intubation

Exclusion criteria

Exclusion criteria: allergy to drugs elevated intracerebral or intraocular pressure hypertention (Blood Pressure>= 160/110 mm Hg) severe endocrine disorders active lung disease tracheal stenosis obstructive sleep apnea airway obstruction laryngospasm pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
Death at emergency department or during admission at hospital. Timepoint: During emergency department and hospital admission. Method of measurement: Death declaration at his/her documents.;Duration of survival days during hospital admission. Timepoint: During emergency or hospital admission (from admission and intubation until death). Method of measurement: Number of survival days.;ICU-free days. Timepoint: During hospital admission from intubation to 28 days after admission (ICU-discharge point until 28 days after admission). Method of measurement: Number of ICU-free days.;Ventilator-free days. Timepoint: During hospital admission from intubation to 28 days after admission (the time of weaning from mechanical ventilation until 28 days after admission). Method of measurement: Number of ventilator-free days.;Vasopressor free days. Timepoint: During hospital admission from intubation to 28 days after admission (the time of stopping vasopressor infusion until 28 days after admission). Method of measurement: Number of vasopressor-free days.

Secondary

MeasureTime frame
Number of transfused packed-RBCs. Timepoint: During the first 48 hours from admission. Method of measurement: Number of transfused packed-RBCs documented on patient file.;Sepsis incidence. Timepoint: During the first 28 days from admission. Method of measurement: Having 2 or more criteria form SIRS associated with an infection focus during the first 28 days from admission.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamed Sotoude

Sanandaj University of Medical Sciences

H-sotude@razi.tums.ac.ir+98 87 3366 2027

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026